Neoadjuvant Lu-PSMA Radioligand Therapy and Ipilimumab in Men With Very High-risk Prostate Cancer
Clinical trial NCT06388369 · TERMINATED
Trial details
- NCT number
- NCT06388369
- Sponsor
- University Hospital, Essen
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-08-25
- Primary completion
- 2026-03-09
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.